Anton Lennikov, MD, PhD, Schepens Eye Research Institute, Boston, USA
Carlos Rocha-de-Lossada, MD, PhD, Qvision VITHAS Almería Hospital, VITHAS Málaga, Hospital Regional Universitario de Málaga, Universidad de Sevilla, Spain
BMC Ophthalmology called for submissions to our Collection on the latest developments, breakthroughs, and research in the rapidly evolving area of corneal transplantation.
Anton Lennikov, MD, PhD, Schepens Eye Research Institute, Boston, USA
Dr Anton Lennikov is a dedicated scientist interested in unraveling the intricacies of ocular immunology in corneal and retinal disorders. His scientific journey has spanned esteemed institutions worldwide, including Hokkaido University, Sapporo Medical University in Japan, Johns Hopkins University in the USA, and Linkoping University in Sweden. With expertise in ocular immunology, angiogenesis, and ocular inflammation, Dr Lennikov currently holds the position of Instructor in Ophthalmology at the Schepens Eye Research Institute. He is focused on deciphering the immune mechanisms underlying retinal inflammatory and degenerative diseases. Driven by a profound commitment, he strives to propel the boundaries of eye research.
Carlos Rocha-de-Lossada, MD, PhD, Qvision VITHAS Almería Hospital, VITHAS Málaga, Hospital Regional Universitario de Málaga, Universidad de Sevilla, SpainDr Carlos Rocha-de-Lossada MD, PhD, FEBO graduated from the University of Cordoba, Spain. He completed his residency in ophthalmology at the Hospital Regional Universitario de Málaga, Spain and his fellowship in cornea, anterior segment and ocular surface at the Hospital Clinic in Barcelona, Spain. He is currently a consultant ophthalmic surgeon specialized in cornea, ocular surface, presbyopia, cataract, and refractive surgery and holds an Associate Professor position at the University of Seville, Spain. Dr Rocha-de-Lossada has a special interest in research and has published in many peer-reviewed journals.
BMC Ophthalmology is calling for submissions to our Collection on corneal transplantation.
This Collection aims to address conditions such as corneal scarring, opacities, keratoconus, ectasias, corneal edema, or other diseases affecting the clarity and function of the cornea. The field of corneal transplantation has witnessed significant advancements in recent years, driven by innovative technologies that aim to enhance surgical outcomes, improve patient experiences, and address challenges associated with traditional transplantation methods.
This Topical Collection aims to showcase the latest developments, breakthroughs, and research in this dynamic and rapidly evolving area. Topics accepted for submission include:
Image credit: Microgen / stock.adobe.com
To compare the difference in rebubbling rates between patients undergoing Descemet membrane endothelial keratoplasty (DMEK) with endothelium-in using a standard IOL cartridge and those with endothelium-out DME...
Ochrobactrum anthropi is widely distributed and primarily infects patients with compromised immune functions . Historically, O. anthropi has been considered to possess low toxicity and pathogenicity; however, ...
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "New technologies in corneal transplantation" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.